Premium Industrial News

Peru Lauds Sinopharm's COVID-19 Vaccine

Peru Lauds Sinopharm's COVID-19 Vaccine

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 131 Words

BEIJING--August 30, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--According to Peru's Ministry of Health, China's Sinopharm vaccine has reduced Peru's COVID-19 mortality rate by 98% among those who received two doses. Only 5.2% of those vaccinated were later infected, and at least 9% were able to produce neutralizing antibodies.

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now!(All Fields Required)

Subscription Type:

  • Pay-Per-Article - $5.95
  • Annual Premium News Subscription - $365.00
Pricing Help?